Study Entry Criteria Based on WHO criteria, an abnormal spermogram was defined as follows in at least two samples taken four weeks apart: Sperm count less than 20 million per milliliter Total sperm motility less than 50% Forward sperm motility less than 25% Normal sperm morphology less than 30% Normal levels of gonadotropins, testosterone, and prolactin Study Exclusion Criteria Underlying conditions like varicocele grades 3 and 4, testicular atrophy, ejaculation disorders Any medication use in the past two months Patients with azoospermia, endocrine or anatomical disorders, or infections Patients eligible for ICSI due to severe spermogram disorders and other infertility factors Sample Size The sample size was set at 30 participants based on previous studies
Conditionnement disponible Vendu par 60 glules.
External resources SURMOUNT-5 Trial: Tirzepatide vs Semaglutide for Obesity (New England Journal of Medicine) SURPASS-2 Trial: Tirzepatide vs Semaglutide for Type 2 Diabetes (New England Journal of Medicine) Tirzepatide Dual GIP/GLP-1 Receptor Agonist Mechanism (JCI Insight) Why Weight Loss Drugs Do Not Work for Everyone: Genetics (Scientific American) Factors Associated with Weight Loss Response to GLP-1 Analogues (PMC) In case I do not see you, good afternoon, good evening, and good night
Watanabe et al 10 investigated the impact of 2% w/w GSSG lotion on TEWL using a Corneometer (Courage + Khazaka electronic GmbH)
Instead, the medication works through complex mechanisms involving brain appetite centers and delayed gastric emptying
Preclinical rodent studies consistently showed that this combined effect produced greater fat mass reduction than either single or dual agonism, while maintaining glucose homeostasis